S. 2220 · 118th Congress · Commerce

PREVAIL Act

Died in the Senate13k words Introduced Jul 10, 2023 · Latest action Dec 2, 2024

How far it has goneStopped at 3 of 6 · Died in the Senate
  1. IntroducedJul 10, 2023 Done
  2. CommitteeReported Dec 2, 2024 Done
  3. Senate floorDied Jan 3, 2025 Stopped here
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

30 organizations · 133 filings · Q3 2023–Q4 2024

See which of this bill’s sponsors and cosponsors got money from the lobbying organizations’ PACs → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Chamber of Commerce of the U.s.a. 6 of 6 quarters
    “…S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2780, Medication Affordability and Patent Integrity Act S.5160, A bill to expand the sharing of information with respect to suspected violations of intellectual property rights in trade Potential legislation similar to…”

    $74.5M lobbying spend in 2024, all issuesQ4 2024 filing

  2. Pharmaceutical Research and Manufacturers of America 6 of 6 quarters
    “…S. 2220: PREVAIL Act - Provisions related to the PTAB S. 2780: Medication Affordability and Patent Integrity Act S. 3583: A bill to address patent thickets. - Provisions related to patents S. 4878: REMEDY Act S. 5573: A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a…”

    $31.0M lobbying spend in 2024, all issuesQ4 2024 filing

  3. Amgen Inc 6 of 6 quarters
    “…S.2220/HR 4370 Promoting and Respecting Economically Vital American Innovation Leadership Act S.1128: A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents H.R. 3858/S.1834: A bill to prohibit the President from negotiating or concluding…”

    $11.6M lobbying spend in 2024, all issuesQ4 2024 filing

27 more organizations, every filingPROUpgrade

Organizations that named S. 2220 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

5 actions · newest first
  1. Dec 2, 2024Placed on Senate Legislative Calendar under General Orders. Calendar No. 650.
  2. Dec 2, 2024Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
  3. Nov 21, 2024Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. Jul 10, 2023Read twice and referred to the Committee on the Judiciary.
Show all 5 actionsShow fewer
  1. Jul 10, 2023Introduced in Senate